Skip to navigation Skip to content

Disease Courses

Share

In this article

Overview

Multiple sclerosis is a chronic, progressive disease that leads to increasing disability in many individuals. Approximately 85 percent of individuals initially present with a  relapsing-remitting course of the disease (Lublin et al., 2013). Most people with relapsing remitting MS transition to a more progressive course called secondary-progressive MS (SPMS) that is characterized by accumulation of disability with fewer relapses. About 10 to 15 percent of people with MS begin the disease with a progressive course, without relapses, known as primary progressive MS (PPMS).

In 2013, the International Advisory Committee on Clinical Trials of MS identified four MS disease courses  (Lublin et al., 2013) . In 2020 this group further clarified the concepts underlying these disease courses, highlighting the need for time framing the disease course modifiers “activity” and “progression”  (Lublin et al., 2020). The Committee also clarified the terms “worsening” and “progression” and provided guidance for their use.

Additional resources

Diagnosis & Management Healthcare Professional App

Download this FREE tool and resource that provides a concise compilation of current, easy-to-reference, evidence-based information.

Share


Become a Research Champion

An MS Research Revolution

Support MS Research

Understanding and ending MS can’t come fast enough – it will take all of us working together. It’s easy to be a champion for MS Research – join us and proudly let everyone know that you’re helping to lead the MS Research Revolution.

Become a Research Champion

Become a Research Champion
© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization and our Identification Number (EIN) is 13-5661935.